(Update) Acalabrutinib in CLL and MCL
Acalabrutinib
Zanubrutinib
Obinutuzumab
ASH: COVID-19 Resources for Managing Blood Cancers
Cancer.gov
NCCN Guidelines for Patients for CLL
CLL Society